| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $35.4M | +90.3% |
| SG&A Expense | $15.0M | -14.4% |
| Operating Income | -$58.1M | -1.4% |
| Pre-tax Income | -$80.8M | -42.3% |
| Income Tax | $3.2M | +3594.3% |
| Net Income | -$84.0M | -47.8% |
| EPS (Basic) | -$1.68 | -28.2% |
| EPS (Diluted) | -$1.68 | -28.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -6.5% |
| Current Assets | $22.9M | -48.0% |
| Total Assets | $93.5M | -18.3% |
| Current Liabilities | $43.2M | +493.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $129.2M | +53.2% |
| Stockholders' Equity | -$35.7M | -218.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.4M | -29.8% |
| Capital Expenditures | $352K | +37.0% |
| Investing Cash Flow | $23.2M | +6.0% |
| Financing Cash Flow | $17.9M | +475.1% |
| Free Cash Flow | -$41.8M | -29.9% |